Last reviewed · How we verify

NCT02302677: BAS

The Effect of Sleeve Gastrectomy on Post-prandial Serum Bile Acids

Completed Last updated 6 September 2023
What this trial tests

trial in Obesity in 40 participants. Completed in 20 September 2017.

Timeline
1 January 2015
Primary endpoint
15 August 2016
20 September 2017

Quick facts

Lead sponsorUniversity of Nebraska
StatusCompleted
Study typeOBSERVATIONAL
Enrollment40
Start date1 January 2015
Primary completion15 August 2016
Estimated completion20 September 2017
Sites1 location across United States

Conditions studied

Sponsor

University of Nebraska

Who can join

Adults 19 to 70, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective study of meal-induced bile acid physiology before and after sleeve gastrectomy (SG) surgery. Weight loss and metabolic improvement associated with weight loss surgery cannot be entirely attributed to restriction in stomach size and food intake. Bile acids (BAs), amphipathic steroids that have a role in lipid uptake and metabolism in the gastrointestinal tract, are involved in post-prandial glucose homeostasis and energy expenditure \& are a potential intermediary in weight loss following bariatric surgery. It is unknown if SG increases post-prandial BAs in humans and if an increase in BA signaling impacts weight loss and co-morbidity resolution after surgery. The investigators hypothesis is that SG will increase the post-prandial serum and urine BAs and that the change in the BA profile is a mechanism for restriction-independent weight-loss following SG. SG patients will undergo a meal challenge pre-operatively, and at 1, 3, and 12 months post-operatively, with measurement of post-prandial serum and urine BAs and downstream hormones, glucagon-like peptide 1 (GLP-1) and fibroblast growth factor 19 (FGF19), and a scoring of satiety before and after the meal challenge using a Visual Analog Scale. Serum insulin, glucose, and C4 levels will also be measured to assess metabolic changes associated with SG. Serum and urine BA levels will be compared to post-operative excess weight loss at 12 months. Before and after each meal challenge, patients will be asked to score satiety, and this will be correlated to weight loss, bile acids, GLP-1, and FGF19.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Increased glycine-amidated hyocholic acid correlates to improved early weight loss after sleeve gastrectomy.
    Kindel TL, Krause C, Helm MC, McBride CL, et al · · 2018 · cited 14× · PMID 28779240 · DOI 10.1007/s00464-017-5747-y

Verify or expand the search:

Other recruiting trials for Obesity

Currently open trials in the same condition.

Other University of Nebraska trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02302677.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing